Forest Labs, Allergy Asthma Research Institute sign up with SAFE-BioPharma … – Pharmaceutical Business Review

Forest Labs, Allergy Asthma Research Institute sign up with SAFE-BioPharma
Pharmaceutical Business Review
Forest Laboratories and Allergy Asthma Research Institute have joined SAFE-BioPharma Association to have access to the SAFE-BioPharma digital identity and signature standard for the verification and management of digital identities involved in
Forest Laboratories and Allergy Asthma Research Institute Join SAFE-BioPharma PharmiWeb.com (press release)

all 2 news articles »

View full post on asthma – Google News

Targacept initiates two anti-inflammatory drug studies – Pharmaceutical Business Review

Targacept initiates two anti-inflammatory drug studies
Pharmaceutical Business Review
Targacept has initiated two separate Phase II studies of its product candidate TC-6987 in disorders characterised by inflammation, in asthma and Type II
Targacept to begin Phase 2 trials of drug that could treat asthma, diabetesWinston-Salem Journal
Targacept starts new trial for diabetes drugBizjournals.com
TARGACEPT : Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and 4-traders (press release)

all 18 news articles »

View full post on asthma – Google News

Fitness First Launches Asthma UK Fundraising With Balloons Over Dorset – Stock Markets Review (press release)

Fitness First Launches Asthma UK Fundraising With Balloons Over Dorset
Stock Markets Review (press release)
Fitness First marked its new fundraising partnership with Asthma UK (Friday November 19) by releasing 100 green helium filled balloons from Fitness First''s
Asthma UK and Fitness FirstThird Sector

all 7 news articles »

View full post on asthma – Google News

Dr Reddy’s introduces Zafirlukast tablets in US – Pharmaceutical Business Review

Dr Reddy's introduces Zafirlukast tablets in US
Pharmaceutical Business Review
Accolate, an oral prescription medicine used to treat asthma, works by blocking substances in the body called leukotrienes, which may contribute to the
Dr Reddy's gets nod to launch ZafirlukastSify
Dr. Reddy's launches generic asthma drug in USMarketWatch
Dr Reddy's gets FDA nod to launch anti-asthma tablets in USEconomic Times
India Infoline.com
all 49 news articles »

View full post on asthma – Google News

SOHM adds 6 new asthma, respiratory generic drugs in India – Pharmaceutical Business Review

SOHM adds 6 new asthma, respiratory generic drugs in India
Pharmaceutical Business Review
North American-based SOHM is a generic pharmaceutical manufacturer that produces and markets generic drugs, covering all major treatment categories.
SOHM India Targets $600 Million Generic Drug Market for Asthma and Respiratory MarketWatch (press release)

all 29 news articles »

View full post on asthma – Google News